Top compounds associated with response to TTC26


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC 0.079 0.2
mRNA AS601245 GDSC1000 pan-cancer AAC -0.046 0.2
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.045 0.2
mRNA JQ12 GDSC1000 pan-cancer AAC -0.046 0.2
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.2
mRNA AR-42 GDSC1000 pan-cancer AAC -0.04 0.2
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.064 0.2
mRNA PX-12 CTRPv2 pan-cancer AAC 0.039 0.2
mRNA Doxorubicin FIMM pan-cancer AAC 0.18 0.2
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
Download CSV